NCT04951700View on ClinicalTrials.gov

Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia

Active, not recruitingOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions
SchizophreniaAgingDisease CourseBiomarkerNeuroimagingCognitive Dysfunction
Interventions
OTHER

Other

This is not an intervention study

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Texas Southwestern Medical Center

OTHER